UPS Announces Launch of Temperature True® Cryo in Europe

UPS’ Temperature True® Cryo allows customers to ship parcels in a cryogenic environment.

The service includes real-time tracking and intervention, which when combined with UPS’s risk mitigation solutions and global network of control towers will provide complete visibility for shipments at every stage of the supply chain journey.

This solution uses Cryoport’s cryogenic containers, which allow UPS customers to use liquid nitrogen stored in dry vapour form to keep products frozen at -150°C for 10 days while in transit or storage. When meeting minimum volume levels, shipments can also be paired with UPS Proactive Response® Secure, a financial protection service that provides coverage for these time and temperature-sensitive shipments.

"When products requiring cryopreservation are on the move, customers want peace of mind that their shipments are safeguarded, so bringing this solution to the Europe market was a logical next step as we continue to expand our best-in-class logistics services globally for the healthcare and life science industries," said UPS Europe’s director of healthcare marketing and strategy Jan Denecker.

"UPS Temperature True Cryo combines innovative packaging, 24/7 monitoring, and intervention capabilities for the most critical time and temperature-sensitive specimens across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health."

The most recent UPS Pain in the Chain survey shows product security, damage, and spoilage continue to be top of mind for healthcare executives. The new UPS Temperature True Cryo service along with UPS Proactive Response Secure will add tremendous value to researchers, lab technicians, and healthcare practitioners shipping often-invaluable specimens and samples requiring cryopreservation.

The UPS Temperature True® portfolio offers broad storage, transportation and packaging services for products ranging from cryogenic to ambient, specifically tailored for companies in the pharmaceutical, biotech, and medical device industries. These services are complemented by extensive regulatory expertise and a global network of 51 UPS healthcare-dedicated facilities.

More About This Company